FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976504918> ?p ?o ?g. }

• W1976504918 endingPage "954" @default.
• W1976504918 startingPage "943" @default.
• W1976504918 abstract "Clinical and preclinical data show a wide variability of tumour response to combined inhibition of the Epidermal Growth Factor Receptor (EGFR) and radiotherapy or chemotherapy. Differences are obvious not only between different tumour entities, but also between different combination schedules and different classes of drugs. The underlying reasons are currently not well understood.In light of the disappointing results of some phase III trials on combined EGFR tyrosine kinase (TK) inhibition and chemotherapy in non-small-cell lung cancer, but also of some early clinical trials on the triple combination of EGFR inhibitors and radio-chemotherapy, negative interactions between the components of the treatment cannot be ruled out. Also, there is increasing evidence for a differential activity of anti-EGFR antibodies and EGFR-TK inhibitors. Potential reasons are an immunogenic component of the cytotoxic effect of chimeric antibodies, alternative signal transduction pathways leading to acquired resistance against the drugs, different effects on tumour micromilieu or nutritional supply, differences in pharmacokinetics and intratumoural distribution or different effects on cancer stem cells. Clarifying these potential mechanisms will require further preclinical and clinical research effort but could in future enable us to individually tailor the use of molecular targeted drugs in order to fully utilise their high potential in cancer therapy." @default.
• W1976504918 created "2016-06-24" @default.
• W1976504918 creator A5028492548 @default.
• W1976504918 creator A5065283858 @default.
• W1976504918 creator A5066236221 @default.
• W1976504918 creator A5083101824 @default.
• W1976504918 date "2009-11-01" @default.
• W1976504918 modified "2023-10-16" @default.
• W1976504918 title "Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: Differences between antibodies and TK inhibitors" @default.
• W1976504918 cites W1964071325 @default.
• W1976504918 cites W1967494335 @default.
• W1976504918 cites W1968366677 @default.
• W1976504918 cites W1968376057 @default.
• W1976504918 cites W1971224918 @default.
• W1976504918 cites W1977340600 @default.
• W1976504918 cites W1977703188 @default.
• W1976504918 cites W1978331029 @default.
• W1976504918 cites W1983660720 @default.
• W1976504918 cites W1985292397 @default.
• W1976504918 cites W1992514491 @default.
• W1976504918 cites W1997203401 @default.
• W1976504918 cites W1998971866 @default.
• W1976504918 cites W2002226820 @default.
• W1976504918 cites W2007535198 @default.
• W1976504918 cites W2012184890 @default.
• W1976504918 cites W2019116727 @default.
• W1976504918 cites W2027557150 @default.
• W1976504918 cites W2030335946 @default.
• W1976504918 cites W2033758838 @default.
• W1976504918 cites W2036472365 @default.
• W1976504918 cites W2037260987 @default.
• W1976504918 cites W2041704644 @default.
• W1976504918 cites W2048454485 @default.
• W1976504918 cites W2050587856 @default.
• W1976504918 cites W2059766605 @default.
• W1976504918 cites W2059890247 @default.
• W1976504918 cites W2061349611 @default.
• W1976504918 cites W2063156737 @default.
• W1976504918 cites W2072608181 @default.
• W1976504918 cites W2085522693 @default.
• W1976504918 cites W2086560827 @default.
• W1976504918 cites W2087987371 @default.
• W1976504918 cites W2088597803 @default.
• W1976504918 cites W2093207065 @default.
• W1976504918 cites W2093613683 @default.
• W1976504918 cites W2094882473 @default.
• W1976504918 cites W2097121246 @default.
• W1976504918 cites W2097191207 @default.
• W1976504918 cites W2097702370 @default.
• W1976504918 cites W2099776053 @default.
• W1976504918 cites W2100189272 @default.
• W1976504918 cites W2101318315 @default.
• W1976504918 cites W2106412408 @default.
• W1976504918 cites W2110835998 @default.
• W1976504918 cites W2111491167 @default.
• W1976504918 cites W2112266802 @default.
• W1976504918 cites W2112845420 @default.
• W1976504918 cites W2119351872 @default.
• W1976504918 cites W2121057526 @default.
• W1976504918 cites W2122553809 @default.
• W1976504918 cites W2122900223 @default.
• W1976504918 cites W2125662786 @default.
• W1976504918 cites W2126515711 @default.
• W1976504918 cites W2127101185 @default.
• W1976504918 cites W2131122219 @default.
• W1976504918 cites W2138297714 @default.
• W1976504918 cites W2139519829 @default.
• W1976504918 cites W2142564546 @default.
• W1976504918 cites W2145127518 @default.
• W1976504918 cites W2145915855 @default.
• W1976504918 cites W2146331622 @default.
• W1976504918 cites W2147699387 @default.
• W1976504918 cites W2150179917 @default.
• W1976504918 cites W2152609192 @default.
• W1976504918 cites W2152755651 @default.
• W1976504918 cites W2153477391 @default.
• W1976504918 cites W2153865661 @default.
• W1976504918 cites W2153942353 @default.
• W1976504918 cites W2155384808 @default.
• W1976504918 cites W2156700619 @default.
• W1976504918 cites W2158134441 @default.
• W1976504918 cites W2158453396 @default.
• W1976504918 cites W2159492594 @default.
• W1976504918 cites W2160300997 @default.
• W1976504918 cites W2162017067 @default.
• W1976504918 cites W2162724777 @default.
• W1976504918 cites W2165254737 @default.
• W1976504918 cites W2166630278 @default.
• W1976504918 cites W2167341806 @default.
• W1976504918 cites W2168479321 @default.
• W1976504918 doi "https://doi.org/10.3109/09553000903232835" @default.
• W1976504918 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19895271" @default.
• W1976504918 hasPublicationYear "2009" @default.
• W1976504918 type Work @default.
• W1976504918 sameAs 1976504918 @default.
• W1976504918 citedByCount "38" @default.
• W1976504918 countsByYear W19765049182012 @default.
• W1976504918 countsByYear W19765049182013 @default.

• next